Insider · CIK 0001614890

Melincoff Gwen A

Reports to the SEC for 6 companies · CARMIEL

sec.gov

Transactions

Companies

Filings

CIK

0001614890

Forms 4 and 5

Insider transactions

38 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-03	PLXProtalix BioTherapeutics, Inc. · Restricted Stock UnitsA Award	Director	AAward	+8,500 sh	—	—	8,500
2026-09-03	PLXProtalix BioTherapeutics, Inc. · Stock Options (Right to Buy)A Award	Director	AAward	+17K sh	—	—	17,000
2026-07-15	GANXGain Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+25K sh	—	—	25,000
2025-09-03	PLXProtalix BioTherapeutics, Inc.A Award	Director	AAward	+7,500 sh	—	—	7,500
2025-09-03	PLXProtalix BioTherapeutics, Inc. · Stock Options (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2025-06-24	GANXGain Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+15K sh	—	—	15,000
2024-06-24	GANXGain Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+15K sh	—	—	15,000
2024-05-16	COLLCOLLEGIUM PHARMACEUTICAL, INCA Award	Director	AAward	+7,693 sh	—	—	52,468
2023-09-29	PLXProtalix BioTherapeutics, Inc. · Stock Options (Right to Buy)A Award	Director	AAward	+61.7K sh	—	—	61,676
2023-06-23	GANXGain Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+10.5K sh	—	—	10,500
2023-05-26	SOLENO THERAPEUTICS INCStock option (right to buy)A Award	Director	AAward	+10K sh	—	—	10,000
2023-05-25	SOLENO THERAPEUTICS INCStock option (right to buy)A Award	Director	AAward	+2,666 sh	—	—	2,666
2023-05-18	COLLCOLLEGIUM PHARMACEUTICAL, INCA Award	Director	AAward	+9,792 sh	—	—	44,775
2022-09-20	GANXGain Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+10.5K sh	—	—	10,500
2022-09-07	PLXProtalix BioTherapeutics, Inc. · Stock Options (Right to Buy)A Award	Director	AAward	+50K sh	—	—	50,000
2022-06-01	SOLENO THERAPEUTICS INCStock option (right to buy)A Award	Director	AAward	+2,666 sh	—	—	2,666
2022-05-19	COLLCOLLEGIUM PHARMACEUTICAL, INCA Award	Director	AAward	+14K sh	—	—	34,983
2021-06-01	SOLENO THERAPEUTICS INCEmployee stock option (right to buy)A Award	Director	AAward	+31.9K sh	—	—	31,862
2021-05-20	COLLCOLLEGIUM PHARMACEUTICAL, INCA Award	Director	AAward	+9,941 sh	—	—	20,948
2021-01-08	SOLENO THERAPEUTICS INCEmployee stock option (right to buy)A Award	Director	AAward	+40K sh	—	—	81,887
2020-05-20	COLLCOLLEGIUM PHARMACEUTICAL, INC · Stock Option (Right to Purchase)A Award	Director	AAward	+8,095 sh	—	—	8,095
2020-05-20	COLLCOLLEGIUM PHARMACEUTICAL, INCA Award	Director	AAward	+4,047 sh	—	—	11,007
2020-05-18	SOLENO THERAPEUTICS INCEmployee stock option (right to buy)A Award	Director	AAward	+9,530 sh	—	—	9,530
2020-01-20	PLXProtalix BioTherapeutics, Inc. · Stock Options (Right to Buy)A Award	Director	AAward	+40K sh	—	—	40,000
2019-11-19	SOLENO THERAPEUTICS INCP Purchase	Director	PPurchase	+10K sh	$1.54	+$15.4K	10,000
2019-06-10	SOLENO THERAPEUTICS INCEmployee stock option (right to buy)A Award	Director	AAward	+13K sh	—	—	13,000
2019-04-26	SOLENO THERAPEUTICS INCStock Option (Right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2019-04-25	COLLCOLLEGIUM PHARMACEUTICAL, INC · Stock Option (Right to Purchase)A Award	Director	AAward	+9,414 sh	—	—	9,414
2019-04-25	COLLCOLLEGIUM PHARMACEUTICAL, INCA Award	Director	AAward	+4,707 sh	—	—	6,960
2018-05-24	COLLCOLLEGIUM PHARMACEUTICAL, INC · Stock Option (Right to Purchase)A Award	Director	AAward	+4,506 sh	—	—	4,506
2018-05-24	COLLCOLLEGIUM PHARMACEUTICAL, INCA Award	Director	AAward	+2,253 sh	—	—	2,253
2017-08-09	COLLCOLLEGIUM PHARMACEUTICAL, INC · Stock Option (Right to Purchase)A Award	Director	AAward	+25.1K sh	—	—	25,067
2016-11-01	Tobira Therapeutics, Inc.Employee Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−17.8K sh	—	—	0
2016-11-01	Tobira Therapeutics, Inc.Employee Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−15.5K sh	—	—	0
2016-11-01	Tobira Therapeutics, Inc.Employee Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−13.5K sh	—	—	0
2016-01-12	Tobira Therapeutics, Inc.Stock Options (right to buy)A Award	Director	AAward	+17.8K sh	—	—	17,778
2015-07-09	Tobira Therapeutics, Inc.Stock Options (right to buy)A Award	Director	AAward	+15.5K sh	—	—	15,500
2015-05-04	Tobira Therapeutics, Inc.Stock Options (right to buy)A Award	Director	AAward	+13.5K sh	—	—	13,539

Recent filings

Accepted (ET)
Sep 44
Melincoff Gwen A0001614890-26-000002
SEC(opens sec.gov)
Jul 174
Melincoff Gwen A0001104659-26-084435
SEC(opens sec.gov)
Sep 44
Melincoff Gwen A0001415889-25-023706
SEC(opens sec.gov)
Jun 254
Melincoff Gwen A0001641172-25-016538
SEC(opens sec.gov)
Jun 264
Melincoff Gwen A0001493152-24-025341
SEC(opens sec.gov)
May 164
Melincoff Gwen A0001062993-24-010542
SEC(opens sec.gov)
Oct 34
Melincoff Gwen A0001415889-23-013902
SEC(opens sec.gov)
Jun 264
Melincoff Gwen A0001209191-23-039721
SEC(opens sec.gov)
May 264
Melincoff Gwen A0001209191-23-032696
SEC(opens sec.gov)
May 194
Melincoff Gwen A0001062993-23-011815
SEC(opens sec.gov)
Oct 144
Melincoff Gwen A0001209191-22-053697
SEC(opens sec.gov)
Sep 224
Melincoff Gwen A0001209191-22-051009
SEC(opens sec.gov)
Sep 94
Melincoff Gwen A0001104659-22-098944
SEC(opens sec.gov)
May 234
Melincoff Gwen A0001062993-22-013313
SEC(opens sec.gov)
Jun 44
Melincoff Gwen A0000899243-21-022052
SEC(opens sec.gov)
May 244
Melincoff Gwen A0001192482-21-000454
SEC(opens sec.gov)
Jan 124
Melincoff Gwen A0000899243-21-001699
SEC(opens sec.gov)

Companies

Address

C/O PROTALIX BIOTHERAPEUTICS, INC. 2 SNUNIT STREET SCIENCE PARK, POB 455

CARMIEL, 2161401